You are using an older browser version. Please use a supported version for the best MSN experience.

Biohaven Pharma CEO: We're looking to end 30-year drought in new migraine prevention drugs

Jim Cramer speaks with Biohaven Pharmaceutical CEO Vlad Coric on company's late-stage drug to treat migraines.

More From CNBC

image beaconimage beaconimage beacon